Kedudukan dalam Saham
#16184
Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived... Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived cardiomyocyte sheets, undertaking their research, development, production, commercialization, and distribution. The firm's portfolio extends to include cellular, tissue-based, and cell processing products. Furthermore, it offers contract development and manufacturing services, alongside expert consulting. The company, which was incorporated in 2017 and is based in Tokyo, Japan, previously operated under the name Cuore Inc. before adopting Cuorips Inc. in June 2017.
Perubahan (1 hari)
-1.55%
Perubahan (1 tahun)
-26.02%
Perdagangan Cuorips Inc. (4894)
Harga 4894 dengan permodalan pasaran b
Modal pasaran bagi Cuorips Inc.(4894)
Modal Pasaran: $307.63M
Sehingga September 2026, Cuorips Inc. mempunyai modal pasaran sebanyak $307.63M. Ini menjadikan Cuorips Inc. syarikat ke-16184th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Cuorips Inc. dari 2023 hingga 2026
4894 berbanding dengan 5 teratas yang paling popular stocks
| Harga 4894 |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.260T
|
+1,709,644.95%
|
|
|
|
|
$4.779T
|
+1,553,260.51%
|
|
|
|
|
$4.017T
|
+1,305,624.79%
|
|
|
|
|
$3.719T
|
+1,208,938.52%
|
|
|
|
|
$2.734T
|
+888,721.19%
|
